Statistics for ImmunityBio, (id:7756 IBRX)

Valuation metrics

Market cap

3.39B

Enterprise value

4.28B

Trailing P/E (ttm)

-4.43

Forward P/E

-7.73

PEG ratio

-7.73

Price/Sales (ttm)

462.84

Price/Book (mrq)

-5.02

Enterprise Value/Revenue

584.14

Enterprise Value/EBITDA

-12.55

Overview

Shares outstanding

696.53M

Float

165.54M

Shares short

52.75M

% Held by insiders

0.77%

% Held by institutions

0.10%

Average volume (10 days)

5.79M

Average volume (90 days)

Price summary

52-Week low

3.10

52-Week high

10.53

52-Week change

17.26%

Beta

-0.43

50-Day moving average

4.07

200-Day moving average

5.24

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-1,314.33%

Operational effectiveness

Return on assets

-56.35%

Return on equity

99.53%

Income statement

Revenue (ttm)

0.01

Revenue per share (ttm)

0.01

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-341,304,000.00

Net income to common (ttm)

-587,793,984.00

Diluted EPS (ttm)

-0.96

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

130.37M

Total cash per share (mrq)

0.19

Total debt (mrq)

1.02B

Total Debt/Equity (mrq)

-1.46

Current ratio (mrq)

267.60%

Book value per share (mrq)

-1.07

Cash flow

Cash flow statement

-421,363,008.00

Levered free cash flow (LFCF)

-288,759,872.00